Oh, William K <br/><br/>
Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints.  [electronic resource] 

 -  Urologic oncology   
 - 229-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1078-1439 
<br/><br/><label>Standard No.: </label>10.1016/s1078-1439(03)00019-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Androgen Antagonists--administration & dosage<br/>Androgens<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers<br/>Chemotherapy, Adjuvant<br/>Estramustine--administration & dosage<br/>Flutamide--administration & dosage<br/>Humans<br/>Leuprolide--administration & dosage<br/>Male<br/>Neoadjuvant Therapy<br/>Neoplasms, Hormone-Dependent--drug therapy<br/>Palliative Care<br/>Prostatectomy--methods<br/>Prostatic Neoplasms--drug therapy<br/>Randomized Controlled Trials as Topic--methods<br/>Risk